FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

24202000: Ranitidine hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
40621018 Ranitidine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
753813014 Ranitidine hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
12441000188116 ranitidine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
837551000172112 chlorhydrate de ranitidine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranitidine hydrochloride Is a Product containing ranitidine (medicinal product) false Inferred relationship Some
Ranitidine hydrochloride Is a Ranitidine (substance) false Inferred relationship Some
Ranitidine hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine H2 receptor antagonist (disposition) true Inferred relationship Some
Ranitidine hydrochloride Is a Histamine H2 receptor antagonist true Inferred relationship Some
Ranitidine hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Ranitidine (substance) true Inferred relationship Some
Ranitidine hydrochloride Is a allergène médicamenteux false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Ranitidine hydrochloride 150mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 50mg/50mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 150mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 25mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 300mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 150mg gel capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 300mg gel capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 150mg granule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine (as ranitidine hydrochloride) 75 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 25mg/mL injection solution 6mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Alcohol + ranitidine hydrochloride 7.5%vv/16.8mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 25mg/mL injection solution 40mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release effervescent oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 each conventional release effervescent oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 25mg/mL injection solution 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine (as ranitidine hydrochloride) 75 mg effervescent oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine hydrochloride 50mg/50mL intravenous injection solution premixed 50mL bag The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine (as ranitidine hydrochloride) 300 mg effervescent oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Ranitidine 75mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
ranitidine 25 mg/mL, ampoule de 2 mL d'une solution pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some 1
Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some 1
Ranitidine (as ranitidine hydrochloride) 75 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranitidine hydrochloride Inferred relationship Some 1
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release effervescent oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranitidine hydrochloride Inferred relationship Some 1
Ranitidine (as ranitidine hydrochloride) 300 mg effervescent oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranitidine hydrochloride Inferred relationship Some 1
Ranitidine (as ranitidine hydrochloride) 75 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranitidine hydrochloride Inferred relationship Some 1
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranitidine hydrochloride Inferred relationship Some 1
Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranitidine hydrochloride Inferred relationship Some 1
Product containing precisely ranitidine (as ranitidine hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranitidine hydrochloride Inferred relationship Some 1
Product containing precisely ranitidine (as ranitidine hydrochloride) 50 milligram/2 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ranitidine hydrochloride Inferred relationship Some 1
Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranitidine hydrochloride Inferred relationship Some 1
Ranitidine (as ranitidine hydrochloride) 75 mg effervescent oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranitidine hydrochloride Inferred relationship Some 1
Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 each conventional release effervescent oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranitidine hydrochloride Inferred relationship Some 1
Ranitidine (as ranitidine hydrochloride) 25 mg/mL solution for infusion and/or injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranitidine hydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start